MaxLinear (NYSE:MXL) Lowered to Neutral at UBS Group

Share on StockTwits

UBS Group cut shares of MaxLinear (NYSE:MXL) from a positive rating to a neutral rating in a research report sent to investors on Thursday, October 25th, The Fly reports.

Other equities analysts also recently issued reports about the company. Stifel Nicolaus lowered their price target on MaxLinear from $31.00 to $25.00 and set a $17.41 rating for the company in a report on Thursday, July 19th. Needham & Company LLC lowered their price target on MaxLinear from $27.00 to $22.00 and set a buy rating for the company in a report on Friday, June 29th. Zacks Investment Research raised MaxLinear from a strong sell rating to a hold rating in a report on Wednesday, July 11th. Finally, ValuEngine raised MaxLinear from a strong sell rating to a sell rating in a report on Thursday, August 9th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $22.60.

MXL stock opened at $19.39 on Thursday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.99 and a current ratio of 2.62. MaxLinear has a fifty-two week low of $14.87 and a fifty-two week high of $28.06. The company has a market cap of $1.34 billion, a P/E ratio of 22.03, a PEG ratio of 1.44 and a beta of 0.87.

MaxLinear (NYSE:MXL) last released its earnings results on Tuesday, October 30th. The semiconductor company reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.18 by $0.01. MaxLinear had a negative net margin of 11.18% and a positive return on equity of 15.35%. The firm had revenue of $85.00 million for the quarter, compared to analyst estimates of $85.01 million. During the same period in the prior year, the firm earned $0.39 earnings per share. The business’s quarterly revenue was down 25.2% compared to the same quarter last year. Analysts anticipate that MaxLinear will post 0.67 EPS for the current year.

Several hedge funds have recently bought and sold shares of the company. Teachers Advisors LLC boosted its holdings in shares of MaxLinear by 25.5% in the third quarter. Teachers Advisors LLC now owns 149,036 shares of the semiconductor company’s stock valued at $2,963,000 after acquiring an additional 30,282 shares during the period. Captrust Financial Advisors acquired a new stake in shares of MaxLinear in the third quarter valued at approximately $226,000. Macquarie Group Ltd. boosted its holdings in shares of MaxLinear by 13.4% in the third quarter. Macquarie Group Ltd. now owns 4,346,965 shares of the semiconductor company’s stock valued at $86,418,000 after acquiring an additional 512,286 shares during the period. MetLife Investment Advisors LLC boosted its holdings in shares of MaxLinear by 58.7% in the third quarter. MetLife Investment Advisors LLC now owns 42,374 shares of the semiconductor company’s stock valued at $842,000 after acquiring an additional 15,675 shares during the period. Finally, Pacer Advisors Inc. acquired a new stake in shares of MaxLinear in the third quarter valued at approximately $239,000. 94.43% of the stock is owned by institutional investors and hedge funds.

About MaxLinear

MaxLinear, Inc provides radio-frequency (RF), high-performance analog, and mixed-signal communications systems-on-chip solutions (SoCs) for the connected home, wired and wireless infrastructure, and industrial and multi-market applications worldwide. The company offers range of semiconductor products, such as RF receivers and RF receiver SoCs, wireless infrastructure backhaul RF receivers and modem SoCs, laser modulator drivers, transimpedance amplifiers, clock and data recovery circuits, interface solutions, power management products, and data encryption and compression products.

Featured Story: Outstanding Shares

The Fly

Analyst Recommendations for MaxLinear (NYSE:MXL)

Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.